Psychedelic research brings Dems/Reps together to support research… mushrooms really ARE magic!

Quick summary: This article discusses how psychedelics are gaining support in Washington as potential treatments for mental health issues. Once associated with hippie counterculture, psychedelics like psilocybin and MDMA are being studied in clinical trials for their therapeutic potential in treating conditions such as depression and PTSD.

I began working with Ketamine a year ago because the FDA has approved ketamine for treatment-resistant depression. They have also granted “breakthrough therapy” status to psilocybin and MDMA. YESSSS! This is unprecedented and incredibly exciting in terms of being able to help people heal!

Congress members from BOTH parties are championing the research, with hopes of conducting clinical studies on veterans and troops. (Who knew it would be psychedelics that would bring Rep/Dems together?! Mushrooms really are magic!!)

Despite promising results, concerns remain about safety, regulation, and potential abuse. The psychedelics market is projected to grow substantially, but cautious progress is recommended to ensure responsible use and efficacy. One of the key things I took away from the Psychedelic Sciences conference was the responsible use and the need for working with a trained guide/therapist to help integrate the experience to create lasting healing, change and growth.

See the full article here:

https://www.politico.com/news/2023/08/12/medical-psychedelic-drugs-congress-00110851